Yeast infection Market perception with Key Organization Profiles - Gauge to 2023
The Market Research Future provides detailed
analysis of “Global Yeast infection
Market Research Report - Forecast to 2023” by type, by indication and by
end user. The global yeast infection market is expected to grow at a
CAGR of 5.2% during
the forecasted period. Yeast infection is also known as candidiasis.
Candidiasis is an infection caused by numerous types of yeast called Candida.
The most common type of yeast causing infection is Candida albicans.
This yeast is normally present on the skin, in the intestines and vagina, but
under normal conditions it doesn’t cause infection. However, sometimes it can
develop into an infection of the mouth, vagina or skin due to weak immune
response, unhygienic conditions, and other factors.
Yeast infection can occur due to many reasons such
as weak immunity, unhygienic conditions, and presence of a conducive
environment for the growth of the associated microbes. In addition to infants,
people suffering from diabetes, obesity, hypothyroidism, inflammatory disorders
are also prone to catching yeast infection. The global yeast infection market is majorly driven by increasing prevalence
of autoimmune diseases, continuously increasing geriatric population, and increasing
number of patients suffering from HIV. According to the Joint United Nations
Programme on HIV and AIDS (UNAIDS), by the end of 2015, approximately 36.7
million people worldwide were suffering from HIV/AIDS , out of which 1.8
million were children below 15 years. Moreover, rising demand for antifungal
drugs and government support for research & development have fuelled the
market growth. However, side effects of the treatment may hinder the growth of
the market.
Prominent Key Players: Scynexis (US), Synmedic Laboratories (India), Merck & Co., Inc. (US), Astellas (Japan), Bayer AG (Germany), Mentis Pharma Ltd. (India), Abbott (US), Novartis AG (Switzerland), Pfizer Inc. (US), Sanofi (France), ALLERGAN (Ireland), AstraZeneca (UK)
Prominent Key Players: Scynexis (US), Synmedic Laboratories (India), Merck & Co., Inc. (US), Astellas (Japan), Bayer AG (Germany), Mentis Pharma Ltd. (India), Abbott (US), Novartis AG (Switzerland), Pfizer Inc. (US), Sanofi (France), ALLERGAN (Ireland), AstraZeneca (UK)
Segments
The global yeast infection market is segmented on the basis of pathogen, types, treatment, and end users. On the basis of pathogens, the market is segmented into Candida albicans, Candida glabrata, Candida rugosa, and others.
The global yeast infection market is segmented on the basis of pathogen, types, treatment, and end users. On the basis of pathogens, the market is segmented into Candida albicans, Candida glabrata, Candida rugosa, and others.
On the basis of types, the market is categorized
into vaginal yeast infection, skin yeast infection, throat yeast infection, and
others.
On the basis of treatment, the market is segmented
into drug treatment and surgery. Drug treatment is further classified into
cream, ointment, tablet, and suppository.
On the basis of end users, the market is segmented
into hospital, clinics, ambulatory centers and others.
Regional Analysis : The
Americas account for the largest share in the global yeast infection market
owing to presence of huge geriatric population and increasing number of
patients suffering from immune diseases. According to the Autoimmune Registry,
in 2012, approximately 14.7 million Americans were suffering from auto immune
diseases.
Europe is the second largest market and holds a
noticeable share in the global yeast infection market. The European market is
expected to grow significantly during the forecast period owing to availability
of advanced treatment facilities, skilled medical professionals, and government
support for research & development.
Increasing prevalence of HIV in Asia Pacific region
is the crucial factor for the market growth. Rising awareness about the
infections and availability of new treatment methods drive the market in this
region. In Asia Pacific, the market shows growth opportunities in China and
India.
However, the Middle East & Africa is expected
to show the least growth in this market due to some major factors such as lack
of awareness about the yeast infections, limited access and availability of
treatment facilities.
Brief TOC
1 Report Prologue
2 Market Introduction
1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3 Research Methodology
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
…Continued
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
…Continued
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Comments
Post a Comment